Tarek Sahmoud serves as Executive at Context Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Tarek Sahmoud has executed 1 insider transactions totaling $19.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 16, 2022 involved purchasing 10,000 shares valued at $19.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 16, 2022 | CNTX | $19.5K | Purchase | 10,000 | $1.95 | Discretionary |
Tarek Sahmoud currently holds 10,000 shares of Context Therapeutics Inc. (CNTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tarek Sahmoud has been a net buyer of CNTX stock. They have purchased $19.5K and sold $0 worth of shares.
Tarek Sahmoud's most recent insider trade was on Aug 16, 2022, when they purchased 10,000 shares at $1.95 per share.
Get notified when new Form 4 filings are submitted